Livzon Pharmaceutical Group Inc. (LP6.F) released earnings for full year of RMB2.023 billion
The company's earnings came in at RMB2.023 billion, or RMB2.27 per share. This compares with RMB2.061 billion, or RMB2.24 per share, last year.
The company's revenue for the period rose 1.8% to RMB12.020 billion from RMB11.812 billion last year.
Livzon Pharmaceutical Group Inc. earnings at a glance (GAAP) :
-Earnings: RMB2.023 Bln. vs. RMB2.061 Bln. last year.-EPS: RMB2.27 vs. RMB2.24 last year.-Revenue: RMB12.020 Bln vs. RMB11.812 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.